Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
a. The Early Treatment Diabetic Retinopathy Study Group: Photocoagulation for diabetic macular. edema Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch. Ophthalmol 1985; 103: 1796–1806.
Jonas JB, Sofker A . Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 2001; 132(3): 425–427.
Jonas JB, Kressig I, Sofker A, Degenring RF et al. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 2003; 121(1): 57–61.
Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002; 109(5): 920–927.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gupta, R., Negi, A. & Vernon, S. Severe sub conjunctival haemorrhage following intravitreal triamcinolone for refractory diabetic oedema. Eye 19, 590–591 (2005). https://doi.org/10.1038/sj.eye.6701529
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.eye.6701529
This article is cited by
-
Intravitreale Injektion
Der Ophthalmologe (2008)
-
Intravitreal triamcinolone will cause posterior subcapsular cataract in most eyes with diabetic maculopathy within 2 years
Eye (2007)
